Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism
Zhongyang Lu, Yanchun Li, Wing‐Kin Syn, et al.
AJP Endocrinology and Metabolism (2019) Vol. 318, Iss. 2, pp. E131-E144
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance
Jin Wang, Liang Li, Zhou Zhang, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1264-1279.e8
Open Access | Times Cited: 120
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 31
Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential
Andreas Zietzer, Philip Düsing, Laurine Reese, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 10, pp. 1220-1228
Open Access | Times Cited: 47
Influence of metabolic state and body composition on the action of pharmacological treatment of migraine
Noor Bruijn, Romy van Lohuizen, Malgorzata Boron, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase
Hongjiao Xiang, Shengjie Jin, Fenglang Tan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111610-111610
Open Access | Times Cited: 46
Acid sphingomyelinase promotes diabetic cardiomyopathy via NADPH oxidase 4 mediated apoptosis
Ruijiao Liu, Tengfei Duan, Yu Li, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Acid sphingomyelinase downregulation alleviates diabetic myocardial fibrosis in mice
Changnong Chen, Yang Ji, Hao Liu, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
The role of sphingolipids in endoplasmic reticulum stress
Woo‐Jae Park, Joo‐Won Park
FEBS Letters (2020) Vol. 594, Iss. 22, pp. 3632-3651
Open Access | Times Cited: 45
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases
Carolyn Tallon, Kristen R. Hollinger, Arindom Pal, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1656-1668
Open Access | Times Cited: 36
Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism
Bernadette Breiden, Konrad Sandhoff
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9001-9001
Open Access | Times Cited: 36
SFAs facilitates ceramide’s de novo synthesis via TLR4 and intensifies hepatocyte lipotoxicity
Yi Zou, Ling Tian, Liuhua Pei, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114020-114020
Closed Access
Emerging roles of the acid sphingomyelinase/ceramide pathway in metabolic and cardiovascular diseases: Mechanistic insights and therapeutic implications
Hong-Ni Wang, Ye Wang, Siyao Zhang, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 2
Open Access
The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome
Zhongyang Lu, Yanchun Li, Nityananda Chowdhury, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8322-8322
Open Access | Times Cited: 10
Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis
Bruno Ramos‐Molina, Joana Rossell, Alejandra Pérez-Montes de, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis
Cristina Alarcón‐Vila, Naroa Insausti-Urkia, Sandra Torres, et al.
Redox Biology (2023) Vol. 59, pp. 102596-102596
Open Access | Times Cited: 10
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
Yang Ji, Jing Chen, Lihua Pang, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 1, pp. 43-56
Open Access | Times Cited: 12
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Daniel Foran, Charalambos Antoniades, Ioannis Akoumianakis
(2024)
Open Access | Times Cited: 2
Exosomal miR‐155‐5p promote the occurrence of carotid atherosclerosis
Wenwen Yang, Qingxiang Li, Fei Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 21
Open Access | Times Cited: 2
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
Daniela Maria Tănase, Evelina Maria Gosav, Daniela Petrov, et al.
Diagnostics (2021) Vol. 11, Iss. 11, pp. 2053-2053
Open Access | Times Cited: 16
Curcumin alleviates lipopolysaccharides-induced inflammation and apoptosis in vascular smooth muscle cells via inhibition of the NF-κB and JNK signaling pathways
Haohang Ruan, Qing Huang, Benting Wan, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 517-525
Closed Access | Times Cited: 11
Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling
Qian He, Jun Zeng, Kecheng Yao, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 532, Iss. 3, pp. 362-369
Closed Access | Times Cited: 16
Inhibition of acid sphingomyelinase by imipramine abolishes the synergy between metabolic syndrome and periodontitis on alveolar bone loss
Yanchun Li, Zhongyang Lu, Lixia Zhang, et al.
Journal of Periodontal Research (2021) Vol. 57, Iss. 1, pp. 173-185
Open Access | Times Cited: 14
Discovery of Novel N-Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis
Kan Yang, Keyi Nong, Fei Xu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2681-2698
Closed Access | Times Cited: 5
Amitriptyline inhibits NLRP3 inflammasome activation via the ASM/CE pathway in a cell model of NAFLD
Qin Liu, Chun-Yan Niu, QIANG ZHANG, et al.
Biocell (2024) Vol. 48, Iss. 5, pp. 759-769
Open Access | Times Cited: 1
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Daniel Foran, Charalambos Antoniades, Ioannis Akoumianakis
Nutrients (2024) Vol. 16, Iss. 19, pp. 3296-3296
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top